Found: 28
Select item for more details and to access through your institution.
Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 1, p. 15, doi. 10.1093/jac/dkq387
- By:
- Publication type:
- Article
DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 2, p. 275, doi. 10.1093/jac/dkp421
- By:
- Publication type:
- Article
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1592, doi. 10.1093/brain/awac333
- By:
- Publication type:
- Article
Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1166, doi. 10.1002/alz.13528
- By:
- Publication type:
- Article
Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 376, doi. 10.1002/alz.13454
- By:
- Publication type:
- Article
Plasma pTau217: single vs multiple phospho‐site assays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082953
- By:
- Publication type:
- Article
Fast accumulators of tau have higher levels of plasma pTau and stronger associations with amyloid in later Braak regions at baseline.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079999
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080098
- By:
- Publication type:
- Article
Plasma ALZpath p‐tau217 for the identification of amyloid and tau positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079892
- By:
- Publication type:
- Article
Prognostic utility of plasma p217+tau vs amyloid and tau PET in the Alzheimer's continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078042
- By:
- Publication type:
- Article
Plasma p‐tau231 and p‐tau217 provides information on tau tangle deposition in symptomatic Alzheimer's disease individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076691
- By:
- Publication type:
- Article
Plasma biomarkers of tau for the differentiation between slow and fast tau‐PET accumulators.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081969
- By:
- Publication type:
- Article
Plasma p‐tau231 and p‐tau217 inform on tau tangles aggregation in cognitively impaired individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4463, doi. 10.1002/alz.13393
- By:
- Publication type:
- Article
Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 5, p. 1913, doi. 10.1002/alz.12841
- By:
- Publication type:
- Article
A head‐to‐head comparison of plasma phosphorylated tau assays in the real‐world memory clinic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065391
- By:
- Publication type:
- Article
Plasma p217+tau concordance with <sup>18</sup>F‐NAV4694 beta‐amyloid and <sup>18</sup>F‐MK6240 tau PET in mild Alzheimer's disease and cognitively unimpaired participants in the AIBL/ADNeT cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055706
- By:
- Publication type:
- Article
P1‐052: A SINGLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF THE ANTI‐PHOSPHO‐TAU ANTIBODY JNJ‐63733657 IN HEALTHY SUBJECTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P252, doi. 10.1016/j.jalz.2019.06.077
- By:
- Publication type:
- Article
P301L TAU DEMONSTRATES ALTERED MODULATION OF CALMODULIN-DEPENDENT PDE1 AND CALCINEURIN IN VITRO.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P466, doi. 10.1016/j.jalz.2016.06.914
- By:
- Publication type:
- Article
Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080132
- By:
- Publication type:
- Article
A Recombinant Sialidase Fusion Protein Effectively Inhibits Human Parainfluenza Viral Infection In Vitro and In Vivo.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 2, p. 234, doi. 10.1086/653621
- By:
- Publication type:
- Article
Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12307
- By:
- Publication type:
- Article
Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021, v. 13, n. 1, p. 1, doi. 10.1002/dad2.12204
- By:
- Publication type:
- Article
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer's disease.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06217-2
- By:
- Publication type:
- Article
Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01005-8
- By:
- Publication type:
- Article
Tau and other proteins found in Alzheimer's disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 571, p. 1, doi. 10.1126/scitranslmed.aba6334
- By:
- Publication type:
- Article
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15436-0
- By:
- Publication type:
- Article
Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.
- Published in:
- 2018
- By:
- Publication type:
- journal article